Alpha 2.0
Login Register
» Articles » PMID: 8623456

Cost-containment Strategies in Transplantation: the Utility of Cyclosporine-ketoconazole Combination Therapy

Overview
Journal Transplant Proc
Specialty General Surgery
Date 1996 Apr 1
PMID 8623456
Citations 6
Authors
O Odocha
B Kelly
S Trimble
C Murigande
R M Toussaint
C O Callender
Affiliations
Soon will be listed here.
Citing Articles

Combining cytochrome P-450 3A4 modulators and cyclosporine or everolimus in transplantation is successful.

Gonzalez F, Valjalo R World J Transplant. 2016; 5(4):338-47.

PMID: 26722662 PMC: 4689945. DOI: 10.5500/wjt.v5.i4.338.

The use of a cyclosporin-ketoconazole combination: making renal transplantation affordable in developing countries.

Gerntholtz T, Pascoe M, Botha J, Halkett J, Kahn D Eur J Clin Pharmacol. 2004; 60(3):143-8.

PMID: 15083250 DOI: 10.1007/s00228-004-0745-0.

Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.

Pea F, Furlanut M Clin Pharmacokinet. 2001; 40(11):833-68.

PMID: 11735605 DOI: 10.2165/00003088-200140110-00004.

Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.

Venkatakrishnan K, von Moltke L, Greenblatt D Clin Pharmacokinet. 2000; 38(2):111-80.

PMID: 10709776 DOI: 10.2165/00003088-200038020-00002.

The clinical and economic potential of cyclosporin drug interactions.

Martin J, Daoud A, Schroeder T, First M Pharmacoeconomics. 1999; 15(4):317-37.

PMID: 10537952 DOI: 10.2165/00019053-199915040-00001.